Evidence map›Paper›PMID 18054248›Full record

ReviewSeminars in immunology2007

Th17 cells and mucosal host defense.

Shean J Aujla, Patricia J Dubin, Jay K Kolls

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 147 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 1 synthesis or guideline pooled it, 295 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Heat-killedResearch square · 2026
    Article
  4. CD4+ T-cell immunity toDiscover immunity · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. The Complex Dysregulations of CD4 T Cell Subtypes in HIV Infection.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Cross Protectivity Analysis of 49.8 kDa Pili Subunits ofInterdisciplinary perspectives on infectious diseases · 2022
    Article

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shean J AujlaDivision of Pulmonology, Department of Pediatrics, Children's Hospital of Pittsburgh and The University of Pittsburgh, Pittsburgh, PA 15213, USA.
Patricia J Dubin
Jay K Kolls
Children's Hospital of Pittsburgh · USUniversity of Pittsburgh · US

Funding

Surrogate Biomarkers for Disease Progression in IPFP50HL084932 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAY, ANURADHA · 2006 to 2010
$12.2M
Th17 Cytokines and Lung ImmunityR37HL079142 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLLS, JAY K · 2010 to 2017
$3.6M
IL-23 / Il-17 and Lung Host DefenseR01HL079142 · NHLBI · LSU HEALTH SCIENCES CENTER · PI KOLLS, JAY K · 2005 to 2009
$1.9M
NHLBI NIH HHS P50 HL084932NHLBI NIH HHS P50HL084932NHLBI NIH HHS R01 HL079142NHLBI NIH HHS R01HL079142NHLBI NIH HHS R37 HL079142
6 · The paper itself

Abstract

Th17 cells are a new lineage of T-cells that are controlled by the transcription factor RORgammat and develop independent of GATA-3, T-bet, Stat 4 and Stat 6. Novel effector molecules produced by these cells include IL-17A, IL-17F, IL-22, and IL-26. IL-17RA binds IL-17A and IL-17F and is critical for host defense against extracellular planktonic bacteria by regulating chemokine gradients for neutrophil emigration into infected tissue sites as well as host granulopoiesis. Moreover, IL-17 and IL-22 regulate the production of antimicrobial proteins in mucosal epithelium. Although TGF-beta1 and IL-6 have been shown to be critical for development of Th17 cells from naive precursors, IL-23 is also important in regulating IL-17 release in mucosal tissues in response to infectious stimuli. Compared to Th1 cells, IL-23 and IL-17 show limited roles in controlling host defense against primary infections with intracellular bacteria such as Mycobacterium tuberculosis suggesting a predominate role of the Th17 lineage in host defense against extracellular pathogens. However, in the setting of chronic biofilm infections, as that occurs with cystic fibrosis or bronchiectasis, Th17 cells may be key contributors of tissue injury.

Indexed as

Immunity, MucosalAnimalsAutoimmunityBacterial VaccinesCytokinesHumansImmunity, InnateInterleukin-17InterleukinsMucous MembraneReceptors, Interleukin-17Signal TransductionT-Lymphocytes, Helper-InducerT-Lymphocyte SubsetsBacterial VaccinesCytokinesIL17F protein, humanIL26 protein, humanInterleukin-17InterleukinsReceptors, Interleukin-17

Identifiers

PMID18054248
PMCPMC2293278
OpenAlexW2139257870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.